Cite

Aguilera-Castro, L., Ferre-Aracil, C., Garcia-Garcia-de-Paredes, A., Rodriguez-de-Santiago, E., Lopez-Sanroman, A. (2017). Management of complex perianal Crohn’s disease. Ann. Gastroenterol., 230 (1), 33–44.Search in Google Scholar

Ankrum, J., Ong, J., Karp, J. (2014). Mesenchymal stem cells: Immune evasive, not immune privileged. Nat. Biotech., 32, 252–260.10.1038/nbt.2816432064724561556Search in Google Scholar

Augello, A., Tasso, R., Negrini, S., Amateis, A., Indiveri, F., Cancedda, R., Pennesi, G. (2005). Bone marrow mesenchymal progenitor cells inhibit lymphocyte proliferation by activation of the programmed death 1 pathway. Eur. J. Immunol., 35, 1482–1490.10.1002/eji.20042540515827960Search in Google Scholar

Bartholomew, A., Sturgeon, C., Siatskas, M., Ferrer, K., Mcintosh, K., Patil, S., Hardy, W., Devine, S., Ucker, D., Deans, R., Moseley, A., Hoffman, R. (2002) Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp. Hematol., 30, 42–48.Search in Google Scholar

Ciccocioppo, R., Bernardo, M. E., Sgarella, A., Maccario, R., Avanzini, M. A., Ubezio, C., Minelli, A., Alvisi, C., Vanoli, A., Calliada, F., Dionigi, P., Perotti, C., Locatelli, F., Corazzaa, G. R. (2011). Autologous bone marrow-derived mesenchymal stromal cells in the treatment of fistulising Crohn’s disease. Gut, 60 (6), 788–798.10.1136/gut.2010.21484121257987Search in Google Scholar

Cosnes, J., Cattan, S., Blain, A., Beaugerie, L., Carbonell, F., Parc, R., Gendre, J. P. (2002). Long-term evolution of disease behavior of Crohn’s disease. Inflamm. Bowel Dis., 8, 244–250.10.1097/00054725-200207000-0000212131607Search in Google Scholar

Dignass, A., Van Assche, G., Lindsay, J. O., Lemann, M., Soderholm, J., Colombel, J. F., Danese, S., D’Hoore, A., Gassull, M., Gomollon, F. et al. (2010). The second European evidence-based consensus on the diagnosis and management of Crohn’s disease: Current management. J. Crohn’s Colitis, 4, 28–62.10.1016/j.crohns.2009.12.00221122489Search in Google Scholar

Di Nicola, M., Carlo-Stella, C., Magni, M., Milanesi, M., Longoni, P., Matteucci, P., Grisanti, S., Gianni, A. M. (2002). Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood, 99, 3838–3843.10.1182/blood.V99.10.383811986244Search in Google Scholar

Duijvestein, M., Wildenberg, M. E., Welling, M. M., Hennink, S., Molendijk, I., van Zuylen, V. L., Bosse, T., Vos, A. C. W., de Jonge-Muller, E. S. M., Roelofs, H. et al. (2011). Pretreatment with interferon- γ enhances the therapeutic activity of mesenchymal stromal cells in animal models of colitis. Stem Cells., 29,1549–1558.10.1002/stem.69821898680Search in Google Scholar

De la Portilla, F., García-Cabrera, A. M., Rodríguez- Jiménez, R. M., Reyes, M. L., García-Olmo, D. (2016). Autologous and Allogeneic Stem Cell Transplantation for Treatment of Crohn’s Fistulae/New Insights into Inflammatory Bowel Disease. 262 pp. https://www.intechopen.com/books/new-insights-into-inflammatory-bowel-disease/autologous-and-allogeneic-stem-cell-transplantationfor-treatment-of-crohn-s-fistulae (accessed 26 March 2020).Search in Google Scholar

Friedenstein, A., Chailakhyan, R., Latsinik, N., Panasyuk, A., Keiliss-Borok, I. (1974). Stromal cells responsible for transferring the microenvironment of the hemopoietic tissues. Cloning in vitro and retransplantation in vivo. Transplantation, 17, 331–340.10.1097/00007890-197404000-000014150881Search in Google Scholar

García-Olmo, D., García-Arranz, M., Herreros, D., Pascual, I., Peiro, C., Rodríguez-Montes, J. A. (2005). A phase I clinical trial of the treatment of Crohn’s fistula by adipose mesenchymal stem cell transplantation. Dis. Colon Rectum,48 (7), 1416–1423.10.1007/s10350-005-0052-615933795Search in Google Scholar

Garcia-Olmo, D., Herreros, D., Pascual, I., Pascual, J. A., Del-Valle, E., Zorilla, J., De La-Quintana, P., Garcia-Arranz, M., Pascual, M. (2009). Expanded adipose-derived stem cells for the treatment of complex perianal fistula: A phase ii clinical trial. Dis. Colon Rectum,52 (1),79–86.10.1007/DCR.0b013e318197348719273960Search in Google Scholar

Gonzalez-Rey, E., Anderson, P., González, M. A., Rico, L., Büscher, D., Delgado, M. (2009). Human adult stem cells derived from adipose tissue protect against experimental colitis and sepsis. Gut, 58 (7), 929–939.10.1136/gut.2008.168534Search in Google Scholar

Hellers, G., Bergstrand, O., Ewerth, S., Holmstrom, B. (1980). Occurrence and outcome after primary treatment of anal fistulae in Crohn’s disease. Gut, 21 (6), 525–527.10.1136/gut.21.6.525Search in Google Scholar

Khalif, I. (2013). Clinical Guidelines for the Diagnosis and Treatment of Adult Patients with Chronic Paraproctitis (fistulas of the anus, fistula of the rectum). Association of Coloproctology Russia, Moscow. 20 pp.Search in Google Scholar

Knyazev, O. V., Parfenov, A. I., Shcherbakov, P. L., Ruchkina, I. N., Konoplyannikov, A. G. (2013). Cell therapy for refractory Crohn’s disease. Cell Technol. Biol. Med., 3, 145–152.10.1007/s10517-013-2297-8Search in Google Scholar

Knyazev, O. V., Parfenov, A. I., Shcherbakov, P. L., Konoplyannikov, A. G., Ruchkina, I. N., Lishchinskaya, A. A. (2014). Combined biological therapy of the fistula form of Crohn’s disease. Clinical demonstration. Ther. Arch., 86 (2), 102–105.Search in Google Scholar

Krampera, M., Glennie, S., Dyson, J., Scott, D., Laylor, R., Simpson, E., Dazzi, F. (2003). Bone marrow mesenchymal stem cells inhibit the response of naïve and memory antigen-specific T cells to their cognate peptide. Blood, 101, 3722–3729.10.1182/blood-2002-07-2104Search in Google Scholar

Le Blanc, K., Tammik, C., Rosendahl, K., Zetterberg, E., Ringden, O. (2003). HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp. Hematol., 31, 890–896.10.1016/S0301-472X(03)00110-3Search in Google Scholar

Lei Yea, Xiaowei Wua, Na Yua, Jingxin Panb, Lianming Liaoc, Fangyu (2016). Clinical efficacy and safety of stem cells in refractory Crohn’s disease: A systematic review. Wang J. Cell. Immunother., 2 (1), 21–27.10.1016/j.jocit.2016.01.001Search in Google Scholar

Lichtenstein, G. R., Van, S., Bala, M., Blank, M., Sands, B. E. (2005). Infliximab maintenance treatment reduces hospitalizations, surgeries, and procedures in fistulizing Crohn’s disease. Gastroenterology, 128, 862–869.10.1053/j.gastro.2005.01.04815825070Search in Google Scholar

Munkholm, P., Langholz, E., Davidsen, M., Binder, V. (1995). Disease activity courses in a regional cohort of Crohn’s. Scand. J. Gastroenterol., 30, 699–706.10.3109/003655295090963167481535Search in Google Scholar

Panes, J. (2016). Stem cell therapy for perianal fistulas in Crohn’s disease. Gastroenterol. Hepatol., 12 (10), 637–640.Search in Google Scholar

Rutgeerts, P., Feagan, B. C., Lichtenstein, G. R., Mayer, LK. F., Schreiber, S., Colombel, J. F., Rachmilewitz, D., Wolf, D. C., Olson, A., Bao, W., Hanauer, S. B. (2004). Comparison of scheduled and episodic treatment strategies of infliximab in Crohn’s disease. Gastroenterology, 126, 402–413.10.1053/j.gastro.2003.11.01414762776Search in Google Scholar

Sachar, D. B., Andrew, H. A., Farmer, R. G., Pallone, F. (1992). Proposed classification of patient subgroups in Crohn’s disease. Gastroenterol. Intern., 5, 141–154.Search in Google Scholar

Sandborn, W. J., Fazio, V. W., Feagan, B. C., Hanauer, S. B. (2003). AGA technical review on perianal Crohn’s disease. Gastroenterology, 125, 1508–1530.10.1016/j.gastro.2003.08.02514598268Search in Google Scholar

Schnitzler, E., Fielder, H., Ferrante, M., Noman, M., Arijs, I., Assche, G. V., Hoffman, I., Van Steen, K., Vermeire, S., Rutgeerts, P. (2009). Mucosal healing predicts long-term outcome for maintenance therapy with infliximab in Crohn’s disease. Inflamm. Bowel Dis., 15, 1295–1301.10.1002/ibd.2092719340881Search in Google Scholar

Schwartz, D. A., Loftus, E. V., Jr., Tremaine, W. J., Panaccione, R., Harmsen, W. S., Zinsmeister, A. R., Sandborn, W. J. (2002). The natural history of fistulizing Crohn’s disease in Olmsted County, Minnesota. Gastroenterology, 122 (4), 875–880.10.1053/gast.2002.3236211910338Search in Google Scholar

Sensebe, L., Krampera, M., Schrezenmeier, H., Bourin, P., Giordano, R. (2010). Mesenchymal stem cells for clinical application. Vox Sang, 98, 93–107.10.1111/j.1423-0410.2009.01227.x19663934Search in Google Scholar

Solberg, I. C., Yarn, M. H., Hoie, O., Stray, N., Sauar, J., Jahsen, J., Moum, B., Lygren, I. (2007). Clinical course in Crohn’s disease: Results of a Norwegian population-based ten-year follow-up study. Clin. Gastroenterol. Hepatol., 5, 1430–1438.10.1016/j.cgh.2007.09.00218054751Search in Google Scholar

Solberg, I. C., Lygren, I., Jahnsen, J., Vatn, M. H. (2008). Mucosal healing after initial treatment may be a prognostic marker for long-term outcome in inflammatory bowel disease. Gut, 57, A15.Search in Google Scholar

Stappenbeck, T., Miyoshi, H. (2009). The role of stromal stem cells in tissue regeneration and wound repair. Science, 324, 1666–1669.10.1126/science.117268719556498Search in Google Scholar

Tang, L. Y., Rawsthorne, P., Bernstein, C. N. (2006). Are perineal and luminal fistulas associated in Crohn’s disease? A population-based study. Clin. Gastroenterol. Hepatol., 4 (9), 1130–1134.10.1016/j.cgh.2006.06.02116905369Search in Google Scholar

Tsyb, A. F., Konoplyannikov, A. G., Kolesnikov, A. I., Pavlov, V. V. (2004). The preparation and use in medicine, cell cultures of mesenchymal stem cells of bone marrow. Bull. Russ. Acad. Med. Sci., 59 (9), 71–76.Search in Google Scholar

Williamson, P. R., Hollinger, M. D., Larch, S. W., Ferrara, A. (1995). Twenty-year review of the surgical management of perianal Crohn’s disease. Dis. Colon. Rectum, 38, 389–392.10.1007/BF020542277720446Search in Google Scholar

Zuk, P., Zhu, M., Ashjian, P., De Ugarte, D., Huang, J., Mizuno, H., Alfonso, Z. C., Fraser, J. K., Benhaim, P., Hedrick, M. H. (2002). Human adipose tissue is a source of multipotent stem cells. Mol. Biol. Cell, 13, 4279–4295.10.1091/mbc.e02-02-010513863312475952Search in Google Scholar

eISSN:
2255-890X
Language:
English
Publication timeframe:
6 times per year
Journal Subjects:
General Interest, Mathematics, General Mathematics